Revenue GrowthStrong revenue growth indicates robust demand for Eurobio-Scientific's diagnostic products, supporting long-term business expansion and market penetration.

Balance Sheet StrengthA strong equity ratio and low debt-to-equity ratio provide financial stability, allowing Eurobio-Scientific to invest in growth opportunities without excessive leverage.

Cash GenerationEffective cash generation relative to net income ensures Eurobio-Scientific can sustain operations and fund future growth initiatives, enhancing long-term viability.

Bears Say

Profitability MarginsDeclining operational efficiency, as indicated by reduced EBIT and EBITDA margins, could hinder Eurobio-Scientific's ability to maintain profitability, impacting long-term financial health.

Operating Cash Flow DeclineA significant decline in operating cash flow may strain liquidity, limiting Eurobio-Scientific's capacity to invest in growth and meet short-term obligations.

Return On EquityA declining return on equity suggests reduced efficiency in generating profits from shareholders' investments, potentially affecting investor confidence and future capital raising.

ALERS FAQ

What was Eurobio-Scientific SA’s price range in the past 12 months?

Eurobio-Scientific SA lowest stock price was €21.80 and its highest was €25.95 in the past 12 months.

What is Eurobio-Scientific SA’s market cap?

Eurobio-Scientific SA’s market cap is €234.63M.

When is Eurobio-Scientific SA’s upcoming earnings report date?

Eurobio-Scientific SA’s upcoming earnings report date is Apr 10, 2026 which is in 47 days.

How were Eurobio-Scientific SA’s earnings last quarter?

Eurobio-Scientific SA released its earnings results on Sep 24, 2025. The company reported €0.235 earnings per share for the quarter, beating the consensus estimate of N/A by €0.235.

Is Eurobio-Scientific SA overvalued?

According to Wall Street analysts Eurobio-Scientific SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Eurobio-Scientific SA pay dividends?

Eurobio-Scientific SA does not currently pay dividends.

What is Eurobio-Scientific SA’s EPS estimate?

Eurobio-Scientific SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Eurobio-Scientific SA have?

Eurobio-Scientific SA has 10,248,871 shares outstanding.

What happened to Eurobio-Scientific SA’s price movement after its last earnings report?

Eurobio-Scientific SA reported an EPS of €0.235 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.197%.

Which hedge fund is a major shareholder of Eurobio-Scientific SA?

Currently, no hedge funds are holding shares in FR:ALERS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Eurobio-Scientific SA

Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.